Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EAHAD 2026: Nine-Year Outcomes of Gene Therapy
February 2026
Nine-year data show sustained safety and reduced bleeding after gene therapy in haemophilia B, although enrichment for full viral capsids did not deliver clear clinical advantages.
Read more
15 Dec 2020
Could This New Model Predict Cytokine Release Syndrome in Immunotherapy Patients?
While many new immunotherapies are increasing cancer survival rates, tools to predict how the immunotherapy will impact a patient’s immune system are not…
15 Dec 2020
Patients with Sickle Cell Disease Identified as a Vulnerable COVID-19 Population
Hospitalisation of patients with sickle cell disease (SCD) who have coronavirus disease (COVID-19) is reported to be notably higher than the average…
23 Nov 2020
EMJ Podcast: Challenges in Achieving and Maintaining Remission in ANCA-associated Vasculitis
This episode, sponsored by Vifor pharma, provides an overview of the current challenges in achieving remission for patients with ANCA-associated vasculitis.
11
Mins
13 Nov 2020
Is Allogeneic Stem Cell Transplantation a Good Option for Paroxysmal Nocturnal Haemoglobinuria?
Paroxysmal nocturnal haemoglobinuria (PNH) is a rare disease of nonmalignant clonal haematopoietic stem cells with an estimated prevalence of 1–16 cases per million, which may be underestimated because of undiagnosed patients…
12
Mins
24 Sep 2020
The Impact of Sickle Cell Disease: Updates in Therapeutics, Treatment, Management, and Future Directions
Although VOC are the hallmark of SCD, a lack of VOC events does not prevent chronic multi-organ damage. Patients with sickle cell anaemia (SCA)…
2
Mins
18 Sep 2020
European LeukemiaNet 2020 Recommendations for Treating Chronic Myeloid Leukaemia: Implications for Ponatinib
Ponatinib is indicated for the treatment of adults with chronic myeloid leukaemia (CML) who are resistant to dasatinib or nilotinib, are intolerant…
9
Mins
17 Sep 2020
Economic Evaluation of Severe Anaemia
Anaemia is characterised by a decrease in the total amount of red blood cells (RBC) and haemoglobin (Hb) levels, reducing the volume of oxygen transported through the blood…
11 Sep 2020
T Cell Function Modulated by Lymph Node Acidity
ACTIVATION of T cells within lymph nodes is an important component of effective immunity, but recent research has shown that this activation may be…
Loading posts...
« Previous
1
…
66
67
68
69
70
…
100
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View